EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms

Rafael S Chagas, Sandro R Marana iD

FEBS Open Bio · 2026-02 · 16 (2) · 365-381

DOI: 10.1002/2211-5463.70128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 24.09.2025. Verfasst von Rafael S Chagas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil. Hauptthemen laut MEDLINE: Enzyme Inhibitors, Glycoside Hydrolase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanisms of reversible inhibitors with a single binding site on enzymes are usually divided into two basic groups: linear and hyperbolic (or partial). Each of these two groups is subdivided into three types: competitive, non‐competitive and mixed. These six mechanisms are often considered separate identities. Here, prompted by the characterization of the inhibition of the wild‐type and mutant β‐glucosidase Sfβgly by imidazole and 2‐amino‐2‐(hydroxymethyl)‐1,3‐propanediol (i.e. Tris), we developed a unifying enzyme kinetic model that integrates these six basic inhibition mechanisms into one. From this model, we deduced a general enzyme kinetic equation that, through modulation of simple parameters (i.e. the relative inhibitor affinity for two binding sites and the reactivity of the enzyme–substrate–inhibitor complex) is converted into the particular kinetic equation of each of those six inhibition mechanisms. In short, we conclude that the six fundamental inhibition mechanisms, linear and hyperbolic, are not separate behaviors but facets of the same general kinetic model presented here.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enzyme InhibitorsGlycoside Hydrolase InhibitorsKineticsImidazolesBinding Sites

Stichwörter der Autor:innen

GH1 β‐glucosidasesTrisimidazoleinhibition mechanisms

Substanzen

ImidazolesEnzyme InhibitorsimidazoleGlycoside Hydrolase Inhibitors

Autor:innen und Institutionen

  • Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.

ORCID-Profile: Sandro R Marana

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Chagas, R. S., & Marana, S. R. (2026). A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms. FEBS Open Bio, 16(2), 365-381. https://doi.org/10.1002/2211-5463.70128

Vancouver

Chagas RS, Marana SR. A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms. FEBS Open Bio. 2026;16(2):365-381. doi:10.1002/2211-5463.70128

BibTeX
@article{Chagas2026,
  author = {Chagas, Rafael S and Marana, Sandro R},
  title = {A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms},
  journal = {FEBS Open Bio},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {365--381},
  doi = {10.1002/2211-5463.70128}
}
Kostenlos starten →